Infliximab Neutralizes the Suppressive Effect of TNF-α on Expression of Extracellular-Superoxide Dismutase in Vitro(Biopharmacy)
スポンサーリンク
概要
- 論文の詳細を見る
Extracellular-superoxide dismutase (EC-SOD) is the major SOD isozyme in blood vessel walls, normal cartilage and synovial fluid and may be important for the antioxidant capability of these tissues. We have reported that EC-SOD gene transferred mice exhibited significant suppression of clinical symptoms of type II collagen induced arthritis [Iyama, et al., Arthritis Rheum., 44, 2160-2167 (2001)] and plasma EC-SOD levels in type 2 diabetic patients were significantly negatively related to indices of insulin resistance [Adachi, et al., J. Endocrinol., 181, 413-417 (2004)]. Tumor necrosis factor-α (TNF-α) has been implicated in the pathological conditions of the above diseases and is a major therapeutic target, based on clinical studies with anti-TNF-α monoclonal antibodies such as infliximab. In this report, we investigated the effect of TNF-α on the expression of EC-SOD in cultured cells and the cooperating effect of infliximab. In the in vitro assays examined, expression of EC-SOD, but not other SOD isozymes, in smooth muscle and fibroblast cells were suppressed by the addition of TNF-α. Simultaneous addition of infliximab dose-dependently and significantly prevented the suppressive effects of TNF-α. p38 mitogen-activated protein kinase (MAPK) inhibitor, SB203580, prevented significantly the suppressive effect of TNF-α suggesting that p38 MAPK is an important signaling molecule downstream of TNF-α to inhibit the EC-SOD expression. From the results, it is speculated that the decline in TNF-α activity by the administration of infliximab results in the liberation of EC-SOD from the suppressed state of gene expression. This reveals a potential usefulness of infliximab on TNF-α related pathological conditions such as arthritis and insulin resistance.
- 公益社団法人日本薬学会の論文
- 2006-10-01
著者
-
TAKASHIMA Eiji
Department of Clinical Pharmacy, Gifu Pharmaceutical University
-
Adachi Tetsuo
Department Of Pharmaceutics Gifu Pharmaceutical University
-
Adachi Tetsuo
Department Of Clinical Pharmaceutics Gifu Pharmaceutical University
-
Takashima Eiji
Department Of Clinical Pharmaceutics Gifu Pharmaceutical University
-
TOISHI Taisuke
Department of Clinical Pharmaceutics, Gifu Pharmaceutical University
-
KARA Hirokazu
Department of Clinical Pharmaceutics, Gifu Pharmaceutical University
-
Kara Hirokazu
Department Of Clinical Pharmaceutics Gifu Pharmaceutical University
-
Toishi Taisuke
Department Of Clinical Pharmaceutics Gifu Pharmaceutical University
関連論文
- 13-6-48 HPLC による医薬品分析における移動相の簡便な設定法の検討
- Effects of Salmeterol Xinafoate and Fluticasone Propionate on Immunological Activation of Human Cultured Mast Cells
- Competitive Enzyme Immunoassay for Anti-ulcer Agent, (-)-cis-2,3-Dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5-benzothiazepin-4(5H)-one Hydrochloride (BTM-1086)
- ヒトα-フェトプロテイン及び血清アルブミンの免疫交叉性とその結合性との関連について
- ヒト胎児血清中のキャリアプロテイン : 血清アルブミン, α-フェトプロテイン及びリガンディンのビリルビン結合能
- α_1-プロテイナーゼインヒビターによるヒト組織カリクレインの阻害について
- ヒト細胞質画分アスパラギン酸アミノトランスフェラーゼのエンザイムイムノアッセイ
- 肝疾患患者血漿カリクレイン-α_2-マクログロブリン複合体の定量
- カチオン性及びアニオン性グルタチオンS-トランスフェラーゼのエンザイムイムノアッセイによる分別定量
- The Immunological Crossreaction between Human α-Fetoprotein and Serum Albumin and Its Relation with the Binding Ability
- アドリアマイシンのエンザイムイムノアッセイ
- 肝炎及び腎炎発症時のスーパーオキシドディスムターゼの挙動
- グルタチオンパーオキシダーゼ, グルタチオンS-トランスフェラーゼによるマイクロゾーム及びリポプロテイン中の過酸化脂質の分解について
- ヒト尿中及び膵臓カリクレインの精製と諸性質
- ヒト肝臓可溶性分画に存在する2種のカルボキシルエステラーゼの薬物水解について
- 病院実務研修に対する本学学生の意識調査
- The Heparin-Binding Site of Human Xanthine Oxidase
- Purification and Characterization of Hamster Hepatic Microsomal N, O-Acetyltransferase
- Enzyme Immunoassay for the Drug of Anti-ulcer Using Avidin-Biotin System
- Hydrolytic Profile for Ester- or Amide-linkage by Carboxylesterases pI 5.3 and 4.5 from Human Liver
- Variable Glyceryl Dinitrate Formation as a Function of Glutathione S-Transferase
- Inhibition of Purified Human Sucrase and Isomaltase by Ethanolamine Derivatives
- EFFECT OF SUPEROXIDE DISMUTASE ON RATS INDUCED KIDNEY INTOXICATION
- SUPEROXIDE DISMUTASE LEVELS FOLLOWING LIVER AND KIDNEY INTOXICATION
- RELATION BETWEEN CARDIOTOXIC EFFECT OF ADRIAMYCIN AND SUPEROXIDE DISMUTASE
- Heparin-Induced Release of Extracellular-Superoxide Dismutase Form (V) to Plasma
- 尿中カリクレイン活性の特異的新測定法
- アドリアマイシンによる心毒性とスーパーオキシドアニオンラジカルとの関係
- An Arginine-213 to Glycine Mutation in Human Extracellular-Superoxide Dismutase Reduces Susceptibility to Trypsin-Like Proteinases
- MOLECULAR ANALYSIS OF EXTRACELLULAR-SUPEROXIDE DISMUTASE GENE ASSOCIATED WITH HIGH LEVEL IN SERUM
- Purification and Characterization of Pranlukast Hydrolase from Rat Liver Microsomes : The Hydrolase is Identical to Carboxylesterase pI 6.2
- Cerebellar Ataxia and Peripheral Neuropathy due to Chronic Bromvalerylurea Poisoning
- Infliximab Neutralizes the Suppressive Effect of TNF-α on Expression of Extracellular-Superoxide Dismutase in Vitro(Biopharmacy)
- Effect of pioglitazone on various parameters of insulin resistance including lipoprotein subclass according to particle size by a gel-permeation high-performance liquid chromatography in newly diagnosed patients with type 2 diabetes